Alnylam Pharmaceuticals

ALNYNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$29.331 B

$219.20 +1.43%

Close of 7 Aug 2026

Revenue

$3.71B

#816 by revenue

Earnings

$313.7M

#821 by earnings

Shares outstanding

133,809,118

Latest filing cover page

P/E ratio

93.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#18Royalty PharmaRPRX$32.6B
#19ZoetisZTS$30.5B
#20Alnylam PharmaceuticalsALNY$29.3B
#21InsmedINSM$28.4B
#22Roivant SciencesROIV$26.3B

Where these numbers come from

Share counts and financials for Alnylam Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.